Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Artitaya Lophatananon

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Cancers|January 28, 2026
The Impact of Endpoint Definitions on Predictors of Progression in Active Surveillance for Early Prostate CancerKieran Sandhu, Artitaya Lophatananon, Vincent J Gnanapragasam
Cancers|October 27, 2022
Risk Factors Associated with Pancreatic Cancer in the UK Biobank CohortTe-Min Ke, Artitaya Lophatananon, Kenneth R Muir
BMJ Open|July 22, 2020
Prediction models for prostate cancer to be used in the primary care setting: a systematic reviewMohammad Aladwani, Artitaya Lophatananon, William Ollier, et al.
International Journal of Molecular Sciences|May 11, 2024
Strengthening the Evidence for a Causal Link between Type 2 Diabetes Mellitus and Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian RandomizationTe-Min Ke, Artitaya Lophatananon, Kenneth R Muir
Biomedicines|September 28, 2024
Exploring the Relationships between Lifestyle Patterns and Epigenetic Biological Age Measures in MenTe-Min Ke, Artitaya Lophatananon, Kenneth R Muir
BMC Medicine|October 8, 2024
The efficacy of different biomarkers and endpoints to refine referrals for suspected prostate cancer: the TARGET study (Tiered integrAted tests for eaRly diaGnosis of clinically significant ProstatE Tumours)Artitaya Lophatananon, Kenneth R Muir, Vincent J Gnanapragasam
Biomedicines|December 23, 2023
An Integrative Pancreatic Cancer Risk Prediction Model in the UK BiobankTe-Min Ke, Artitaya Lophatananon, Kenneth R Muir
BJU International|January 31, 2025
The 5-year results of the Stratified Cancer Active Surveillance programme for men with prostate cancerVincent J Gnanapragasam, Alexandra Keates, Artitaya Lophatananon, et al.
Environmental Epigenetics|April 27, 2026
Epigenetic mechanisms linking hexavalent chromium exposure to pancreatic cancer risk: a systematic reviewKai Hayashi, Yicong Huang, Kenneth R Muir, et al.
Journal of Neurology|December 2, 2025
Physical activity and Alzheimer's disease risk across genetic susceptibility: a prospective UK Biobank study using accelerometer dataSeunghee Na, Kenneth Muir, Artitaya Lophatananon, et al.
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Cancers|January 28, 2026
The Impact of Endpoint Definitions on Predictors of Progression in Active Surveillance for Early Prostate CancerKieran Sandhu, Artitaya Lophatananon, Vincent J Gnanapragasam
Cancers|October 27, 2022
Risk Factors Associated with Pancreatic Cancer in the UK Biobank CohortTe-Min Ke, Artitaya Lophatananon, Kenneth R Muir
BMJ Open|July 22, 2020
Prediction models for prostate cancer to be used in the primary care setting: a systematic reviewMohammad Aladwani, Artitaya Lophatananon, William Ollier, et al.
International Journal of Molecular Sciences|May 11, 2024
Strengthening the Evidence for a Causal Link between Type 2 Diabetes Mellitus and Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian RandomizationTe-Min Ke, Artitaya Lophatananon, Kenneth R Muir
Biomedicines|September 28, 2024
Exploring the Relationships between Lifestyle Patterns and Epigenetic Biological Age Measures in MenTe-Min Ke, Artitaya Lophatananon, Kenneth R Muir
BMC Medicine|October 8, 2024
The efficacy of different biomarkers and endpoints to refine referrals for suspected prostate cancer: the TARGET study (Tiered integrAted tests for eaRly diaGnosis of clinically significant ProstatE Tumours)Artitaya Lophatananon, Kenneth R Muir, Vincent J Gnanapragasam
Biomedicines|December 23, 2023
An Integrative Pancreatic Cancer Risk Prediction Model in the UK BiobankTe-Min Ke, Artitaya Lophatananon, Kenneth R Muir
BJU International|January 31, 2025
The 5-year results of the Stratified Cancer Active Surveillance programme for men with prostate cancerVincent J Gnanapragasam, Alexandra Keates, Artitaya Lophatananon, et al.
Environmental Epigenetics|April 27, 2026
Epigenetic mechanisms linking hexavalent chromium exposure to pancreatic cancer risk: a systematic reviewKai Hayashi, Yicong Huang, Kenneth R Muir, et al.
Journal of Neurology|December 2, 2025
Physical activity and Alzheimer's disease risk across genetic susceptibility: a prospective UK Biobank study using accelerometer dataSeunghee Na, Kenneth Muir, Artitaya Lophatananon, et al.
Pageof 15